Letter: using a placebo as a comparator to rifaximin for the primary prophylaxis of spontaneous bacterial peritonitis-is there really an ethical concern?

被引：1
|
作者：
Thevenot, T. [1 ]
机构：
[1] Hop Jean Minjoz, Serv Hepatol & Soins Intensifs Digestifs, Besancon, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 47卷 / 07期
关键词：
ANTIBIOTIC-PROPHYLAXIS; HEPATORENAL-SYNDROME; A KICK; CIRRHOSIS; ASSOCIATION; MANAGEMENT; ASCITES; LIVER; GUT;
D O I：
10.1111/apt.14544
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1047 / 1048
页数：2
相关论文
共 17 条
  • [1] Norfloxacin versus rifaximin for spontaneous bacterial peritonitis prophylaxis: A randomized controlled trial
    Pala, Sanbanki
    Doke, Purwa
    Maindad, Dadasaheb
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2024, 13 (01) : 112 - 122
  • [2] Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis
    Goel, A.
    Rahim, U.
    Nguyen, L. H.
    Stave, C.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (11-12) : 1029 - 1036
  • [3] A REVIEW OF PRESCRIBING FOR PRIMARY ANTIBIOTIC PROPHYLAXIS IN SPONTANEOUS BACTERIAL PERITONITIS
    Rhead, Camilla
    O'Brien, Alastair
    GUT, 2018, 67 : A115 - A116
  • [4] Safety and Efficacy of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis
    Menshawy', Amr
    Mattarl', Omar
    Barssoumi', Kirolos
    AboEl-Naga, Ammar M.
    Salim, Haitham Mohamed
    Mohamed, Ahmed Mesbah Fahmy
    Elgebaly, Ahmed
    Abd-Elsalam, Sherief
    CURRENT DRUG TARGETS, 2019, 20 (04) : 380 - 387
  • [5] The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
    Hanouneh, Mohamad A.
    Hanouneh, Ibrahim A.
    Hashash, Jana G.
    Law, Ryan
    Esfeh, Jamak Modaresi
    Lopez, Rocio
    Hazratjee, Nyla
    Smith, Thomas
    Zein, Nizar N.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) : 709 - 715
  • [6] Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial
    Praharaj, Dibya L.
    Premkumar, Madhumita
    Roy, Akash
    Verma, Nipun
    Taneja, Sunil
    Duseja, Ajay
    Dhiman, Radha K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 336 - 342
  • [7] Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis
    Facciorusso, Antonio
    Papagiouvanni, Ioanna
    Cela, Marina
    Buccino, Vincenzo R.
    Sacco, Rodolfo
    LIVER INTERNATIONAL, 2019, 39 (08) : 1448 - 1458
  • [8] Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis
    Elfert, Asem
    Abo Ali, Lobna
    Soliman, Samah
    Ibrahim, Shimaa
    Abd-Elsalam, Sherief
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (12) : 1450 - 1454
  • [9] Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art
    Facciorusso, Antonio
    Antonino, Matteo
    Orsitto, Eugenio
    Sacco, Rodolfo
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (08) : 751 - 759
  • [10] Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study
    Assem, M.
    Elsabaawy, M.
    Abdelrashed, M.
    Elemam, S.
    Khodeer, S.
    Hamed, W.
    Abdelaziz, A.
    El-Azab, G.
    HEPATOLOGY INTERNATIONAL, 2016, 10 (02) : 377 - 385
12